We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lapsed IRB Approval Cited in Warning Letter
Lapsed IRB Approval Cited in Warning Letter
February 4, 2009
A clinical investigator did not get informed consent, enrolled an ineligible patient in a clinical trial, let IRB approval lapse and let another clinical investigator work on trials without registering with the FDA, the agency says.